Van der Linden N, Van Olst S, Nekeman S, Uyl-de Groot Carin A, et al. The cost-effectiveness of dapagliflozin compared to DPP-4 inhibitors in the treatment of type 2 diabetes mellitus in the Netherlands. Diabet Med 2020 Aug 3. doi: 10.1111/dme.14371.
PMID: 32745279